Monroe Capital acted as sole lead arranger and administrative agent on the funding of a $125 million senior credit facility to support the recapitalization of a healthcare services company.

The Riverside Company made a simultaneous minority investment as part of the transaction.

The company is a national provider of information that helps doctors improve patients’ lives, with scientific capabilities that can identify potential chronic diseases at stages early enough to make patient lifestyle and wellness improvements successful.